Text Size:AAA

CD31 / PECAM1 Antibody, Rabbit PAb

DatasheetReviewsProtocols
Description: Active  
Expression host: Human Cells  
  • Slide 1
10148-HCCH-50
10148-HCCH-100
10148-HCCH-10
50 µg 
100 µg 
10 µg 
Add to Cart
Description: Active  
Expression host: Human Cells  
  • Slide 1
10148-H02H-200
10148-H02H-100
200 µg 
100 µg 
Add to Cart
Description: Active  
Expression host: Human Cells  
  • Slide 1
10148-H08H-200
10148-H08H-100
200 µg 
100 µg 
Add to Cart
Expression host: Human Cells  
  • Slide 1
50408-M08H-50
50408-M08H-100
50 µg 
100 µg 
Add to Cart

CD31/PECAM-1 ELISA Pair Set

Detection Limit: 156.25 pg/ml
SEK10148-5
SEK10148-15
5 Plates 
15 Plates 
Add to Cart

CD31/PECAM-1 AntibodyRelated Products

Related Products

Featured Reagent Products

CD31/PECAM-1 antibody Background

The Cluster of Differentiation 31 (CD31) adhesion molecule, also known as platelet-endothelial cell adhesion molecule-1 (PECAM-1), is the only known member of the CAM family on platelets. CD31 protein is a 130-kDa transmembrane glycoprotein expressed by endothelial cells, platelets, monocytes, neutrophils, and certain T cell subsets. CD31 protein is also expressed in certain tumors, including epithelioid hemangioendothelioma, other vascular tumors, and histiocytic malignancies. CD31 plays a key role in removing aged neutrophils and tissue regeneration. CD31 protein mediates the homotypic or heterotypic cell adhesion by binding to itself or the leukocyte integrin αvβ3, and thus plays a role in neutrophil recruitment in inflammatory responses, transendothelial migration of leukocytes, as well as in cardiovascular development.

Human CD31/PECAM-1 antibody References
  • Deaglio S, et al. (2000) CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol. 75: 99-120.
  • Kohler S, et al. (2009) Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood. 113(4): 769-74.
  • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"